(Circulation. 1998;98:1837-1841.)
© 1998 American Heart Association, Inc.
Brief Rapid Communication |
From the Washington Hospital Center, The Cardiology Research Foundation, Washington, DC.
Correspondence to Martin B. Leon, MD, Director, Cardiovascular Research, Washington Cardiology Center, 110 Irving St NW, 4B-1, Washington, DC 20010.
Abstract
BackgroundA novel 3-dimensional left ventricular (LV) mapping system uses low-intensity magnetic field energy to determine the location of sensor-tipped electrode catheters within the LV. Using this system, we sought to distinguish between infarcted, ischemic, and normal myocardium by comparing LV electromechanical mapping data with myocardial perfusion imaging studies.
Methods and ResultsUnipolar voltage potentials and local endocardial shortening (LS) were measured in 18 patients (mean age, 58±12 years) with symptomatic chronic angina having reversible and/or fixed myocardial perfusion defects on single photon emission computed tomography imaging studies using 201Tl at rest and 99mTc-sestamibi after adenosine stress. Overall, a significant difference in voltage potentials and LS values was found between groups (P<0.001 for each comparison by ANOVA). The average voltage potentials (14.0±2.0 mV) and LS values (12.5±2.8%) were highest when measured in myocardial segments (n=56) with normal perfusion and lowest (7.5±3.4 mV and 3.4±3.4%) when measured in myocardial segments with fixed perfusion defects (n=20) (P<0.0001). Myocardial segments with reversible perfusion defects (n=66) had intermediate voltage amplitudes (12.0±2.8 mV, P=0.048 versus normal and P=0.005 versus fixed segments) and LS values (10.3±3.7%, P=0.067 versus normal and P=0.001 versus fixed segments).
ConclusionsIn patients with myocardial ischemia, LV mapping, compared with myocardial perfusion imaging, shows (1) mild reduction of endocardial voltage potentials and LS in segments with reversible perfusion defects and (2) profound electromechanical impairment in segments with fixed perfusion defects. Thus, such an LV mapping procedure may allow the detection on-line of myocardial viability in the catheterization laboratory.
Key Words: mapping ventricles myocardium ischemia
This article has been cited by other articles:
![]() |
T. Ota, T. W. Gilbert, S. F. Badylak, D. Schwartzman, and M. A. Zenati Electromechanical characterization of a tissue-engineered myocardial patch derived from extracellular matrix J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 979 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grothues, O. Wolfram, C. Fantoni, H. Boenigk, A. Götte, C. Tempelmann, H.U. Klein, and A. Auricchio Volume measurement by CARTOTM compared with cardiac magnetic resonance. Europace, January 1, 2006; 8(1): 37 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Leon, R. Kornowski, W. E. Downey, G. Weisz, D. S. Baim, R. O. Bonow, R. C. Hendel, D. J. Cohen, E. Gervino, R. Laham, et al. A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1812 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Samady, C. J. Choi, M. Ragosta, E. R. Powers, G. A. Beller, and C. M. Kramer Electromechanical Mapping Identifies Improvement in Function and Retention of Contractile Reserve After Revascularization in Ischemic Cardiomyopathy Circulation, October 19, 2004; 110(16): 2410 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Graf, M. Gyongyosi, A. Khorsand, S. G. Nekolla, C. Pirich, K. Kletter, R. Dudczak, D. Glogar, G. Porenta, and H. Sochor Electromechanical Properties of Perfusion/Metabolism Mismatch: Comparison of Nonfluoroscopic Electroanatomic Mapping with 18F-FDG PET J. Nucl. Med., October 1, 2004; 45(10): 1611 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bolotin, F. H. van der Veen, T. Wolf, R. Shofti, R. Lorusso, S. A. Ben-Haim, and G. Uretzky Use of Novel Nonfluoroscopic Three-Dimensional Electroanatomic Mapping System To Monitor and Analyze Heart Surgery in Animal Models Chest, May 1, 2004; 125(5): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wiggers, H. E. Botker, P. Sogaard, A. Kaltoft, F. Hermansen, W. Y. Kim, L. Krusell, and L. Thuesen Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy J. Am. Coll. Cardiol., March 5, 2003; 41(5): 843 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Keck, K. Hertting, Y. Schwartz, R. Kitzing, M. Weber, B. Leisner, C. Franke, E. Bahlmann, C. Schneider, T. Twisselmann, et al. Electromechanical mapping for determination of myocardial contractility and viability: A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kornowski Left ventricular electromechanical mapping for determination of myocardial function and viability J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1075 - 1078. [Full Text] [PDF] |
||||
![]() |
E. C. Perin, G. V. Silva, R. Sarmento-Leite, A. L.S. Sousa, M. Howell, R. Muthupillai, B. Lambert, W. K. Vaughn, and S. D. Flamm Assessing Myocardial Viability and Infarct Transmurality With Left Ventricular Electromechanical Mapping in Patients With Stable Coronary Artery Disease: Validation by Delayed-Enhancement Magnetic Resonance Imaging Circulation, August 20, 2002; 106(8): 957 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lessick, G. Hayam, A. Zaretsky, S. A. Reisner, Y. Schwartz, and S. A. Ben-Haim Evaluation of inotropic changes in ventricular function by NOGA mapping: comparison with echocardiography J Appl Physiol, August 1, 2002; 93(2): 418 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Johnson, S. Thambar, T. Donahay, M. Dae, and D. O. Williams Effect of Endomyocardial Laser Channels on Regional Innervation Shown with 125I-MIBG and Autoradiography J. Nucl. Med., April 1, 2002; 43(4): 551 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Laham, M. Simons, J. D. Pearlman, K. K. L. Ho, and D. S. Baim Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization J. Am. Coll. Cardiol., January 2, 2002; 39(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gyongyosi, H. Sochor, A. Khorsand, L. Gepstein, and D. Glogar Online Myocardial Viability Assessment in the Catheterization Laboratory via NOGA Electroanatomic Mapping: Quantitative Comparison With Thallium-201 Uptake Circulation, August 28, 2001; 104(9): 1005 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-C. Koch, J. vom Dahl, M. Wenderdel, B. Nowak, W. M. Schaefer, A. Sasse, C. Stellbrink, U. Buell, and P. Hanrath Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization J. Am. Coll. Cardiol., July 1, 2001; 38(1): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Botker, J. F. Lassen, F. Hermansen, H. Wiggers, P. Sogaard, W. Y. Kim, M. Bottcher, L. Thuesen, and A. K. Pedersen Electromechanical Mapping for Detection of Myocardial Viability in Patients With Ischemic Cardiomyopathy Circulation, March 27, 2001; 103(12): 1631 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kornowski, D. S. Baim, J. W. Moses, M. K. Hong, R. J. Laham, S. Fuchs, R. C. Hendel, D. Wallace, D. J. Cohen, R. O. Bonow, et al. Short- and Intermediate-Term Clinical Outcomes From Direct Myocardial Laser Revascularization Guided by Biosense Left Ventricular Electromechanical Mapping Circulation, September 5, 2000; 102(10): 1120 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Patterson and M. S. Runge Therapeutic Myocardial Angiogenesis Via Vascular Endothelial Growth Factor Gene Therapy : Moving on Down the Road Circulation, August 29, 2000; 102(9): 940 - 942. [Full Text] [PDF] |
||||
![]() |
P. R. Vale, D. W. Losordo, C. E. Milliken, M. Maysky, D. D. Esakof, J. F. Symes, and J. M. Isner Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia Circulation, August 29, 2000; 102(9): 965 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kornowski, M. B. Leon, S. Fuchs, Y. Vodovotz, M. A. Flynn, D. A. Gordon, A. Pierre, I. Kovesdi, J. A. Keiser, and S. E. Epstein Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy: Results in normal and ischemic porcine models J. Am. Coll. Cardiol., March 15, 2000; 35(4): 1031 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bhargava and R. Kornowski Biosense Left Ventricular Electromechanical Mapping Asian Cardiovasc Thorac Ann, December 1, 1999; 7(4): 345 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Vale, D. W. Losordo, T. Tkebuchava, D. Chen, C. E. Milliken, and J. M. Isner Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping J. Am. Coll. Cardiol., July 1, 1999; 34(1): 246 - 254. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |